Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

The initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill ...

Jenn’s youngest child left for college this fall, and she anticipated having more energy with her newfound freedom. Instead, ...

Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable, procedureless intragastric balloon, in adults with obesity.

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...